Toggle navigation
Home
Search
Services
Blog
Contact
About
Production of Hybridoma
Wu, Paul
Genelabs Technologies, Inc., Redwood City, CA, United States
Search 27 grants from Paul Wu
Search grants from Genelabs Technologies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Structure and Regulation of the E4 Transcription Factor
Brain Insulin-Like Growth Factor Somatomedin Receptors
Heat, Radiation, and Drugs in Cancer Therapy
Collaborative Proposals: Institute for Theoretical, Atomic, Molecular and Optical Physics
CAA: Molecular Systematic Studies of Selected Genera in the Red Algal Family Rhodomelaceae
Recently added grants:
R38 Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
Hemolysis and Platelet Activation during Continuous Flow Mechanical Circulatory Support
Defining and Controlling Airway Disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research – Phase II (N44)
Project #
N44AI062594-003
Application #
3595492
Study Section
Project Start
1986-08-01
Project End
1988-07-31
Budget Start
1987-09-11
Budget End
1988-07-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Genelabs Technologies, Inc.
Department
Type
DUNS #
City
Redwood City
State
CA
Country
United States
Zip Code
94063
Related projects
NIH 1987
N44 AI
Production of Hybridoma
Wu, Paul / Genelabs Technologies, Inc.
NIH 1986
N44 AI
Production of Hybridoma
Wu, Paul / Genelabs Technologies, Inc.
Comments
Be the first to comment on this grant